Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2011

01.06.2011 | Retinal Disorders

Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography

verfasst von: Michael R. Martinez, Avinoam Ophir

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

To present extrafoveal vitreous traction membranes, and their prevalence and association with diffuse macular oedema in eyes with retinal vein occlusion (RVO), using 3-D spectral-domain optical coherence tomography (SD-OCT).

Methods

In a retrospective institutional observational study, charts and qualified SD-OCT findings of consecutive patients with either central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) associated with macular oedema were analyzed. Exclusion criteria covered eyes that had: 1) another retinopathy that could affect the data analysis, 2) vitreoretinal adherence without signs of retinal traction, 3) undergone vitreoretinal surgery, or 4) been treated by intravitreal administration of medication(s). An age-matched control group (n = 72) afforded the normal central subfield thickness.

Results

Twenty-six eyes (of 26 patients) with either CRVO (n = 12) or BRVO (n = 14) were analyzed. Four eyes were excluded because they had a lack of macular oedema (n = 2), had an earlier pars plana vitrectomy (n = 1), or had previous treatment by intravitreal bevacizumab (n = 1). Of the 22 remaining eyes, both the SD-OCT B-mode video clip and the 3-D image reconstruction enabled a detection of extrafoveal traction membranes, either unifocally or multifocally, in nine eyes: four (of 11; 36.4 %) in CRVO, and five eyes (of 11; 45.5%) in BRVO. The retinal oedema in these nine eyes, which underlined at least one of the traction sites per eye, and the accompanied subretinal fluid in four of these nine eyes, were in continuum in each eye with the diffuse macular oedema and serous macular detachment respectively. During follow-up, a spontaneous release of a traction membrane coupled with resolution of the macular oedema occurred in one eye with BRVO. Of the four eyes that were excluded, two eyes had extrafoveal vitreous traction membranes.

Conclusions

The SD-OCT B-mode video clip and its 3-D image reconstruction enabled relatively frequent detection of extrafoveal vitreous traction membranes in RVO and their association with diffuse macula oedema and macular detachment. A larger cohort is required to validate these findings and to compare the efficacy of early release of such traction membranes, either surgically or possibly by pharmacologic vitreolysis, with the current therapeutic modalities.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wojtkowski M, Bajraszewski T, Targowski P, Kowalczyk A (2003) Real-time in vivo imaging by high-speed spectral optical coherence tomography. Opt Lett 28:1745–1747PubMedCrossRef Wojtkowski M, Bajraszewski T, Targowski P, Kowalczyk A (2003) Real-time in vivo imaging by high-speed spectral optical coherence tomography. Opt Lett 28:1745–1747PubMedCrossRef
2.
Zurück zum Zitat Nassif N, Cense B, Park BH, Yun SH, Chen TC, Bouma BE, Tearney GJ, de Boer JF (2004) In vivo human retinal imaging by ultra-high-speed spectral domain optical coherence tomography. Opt Lett 29:480–482PubMedCrossRef Nassif N, Cense B, Park BH, Yun SH, Chen TC, Bouma BE, Tearney GJ, de Boer JF (2004) In vivo human retinal imaging by ultra-high-speed spectral domain optical coherence tomography. Opt Lett 29:480–482PubMedCrossRef
3.
Zurück zum Zitat Wojtkowski M, Srinivasan V, Fujimoto JG, Ko T, Schuman JS, Kowalczyk A, Duker JS (2005) Three dimensional retinal imaging with high-speed ultra-high resolution optical coherence tomography. Ophthalmology 112:1734–1746PubMedCrossRef Wojtkowski M, Srinivasan V, Fujimoto JG, Ko T, Schuman JS, Kowalczyk A, Duker JS (2005) Three dimensional retinal imaging with high-speed ultra-high resolution optical coherence tomography. Ophthalmology 112:1734–1746PubMedCrossRef
4.
Zurück zum Zitat Schmidt-Erfurth U, Leitgeb RA, Michels S, Povazay B, Sacu S, Hermann B, Ahlers C, Sattmann H, Scholda C, Fercher AF, Drexler W (2005) Three dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 46:3393–3402PubMedCrossRef Schmidt-Erfurth U, Leitgeb RA, Michels S, Povazay B, Sacu S, Hermann B, Ahlers C, Sattmann H, Scholda C, Fercher AF, Drexler W (2005) Three dimensional ultrahigh-resolution optical coherence tomography of macular diseases. Invest Ophthalmol Vis Sci 46:3393–3402PubMedCrossRef
5.
Zurück zum Zitat Pournaras JA, Erginay A, Lazrak Z, Gaudric A, Massin P (2009) Spectral domain optical coherence tomography in diabetic macular edema. Ophthalmic Surg Lasers Imaging 40:548–453PubMedCrossRef Pournaras JA, Erginay A, Lazrak Z, Gaudric A, Massin P (2009) Spectral domain optical coherence tomography in diabetic macular edema. Ophthalmic Surg Lasers Imaging 40:548–453PubMedCrossRef
6.
Zurück zum Zitat Cukras C, Wang YD, Meyerle CB, Forooghian F, Chew EY, Wong WT (2010) Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices. Eye 24:775–783PubMedCrossRef Cukras C, Wang YD, Meyerle CB, Forooghian F, Chew EY, Wong WT (2010) Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices. Eye 24:775–783PubMedCrossRef
7.
Zurück zum Zitat Inoue M, Watanabe Y, Arakawa A, Sato S, Kobayashi S, Kadonosono K (2009) Spectral-domain optical coherence tomography images of inner/outer segment junctions and macular hole surgery outcomes. Graefes Arch Clin Exp Ophthalmol 247:325–330PubMedCrossRef Inoue M, Watanabe Y, Arakawa A, Sato S, Kobayashi S, Kadonosono K (2009) Spectral-domain optical coherence tomography images of inner/outer segment junctions and macular hole surgery outcomes. Graefes Arch Clin Exp Ophthalmol 247:325–330PubMedCrossRef
8.
Zurück zum Zitat Ko TH, Fujimoto JG, Schuman JS, Paunescu LA, Kowalevicz AM, Hartl I, Drexler W, Wollstein G, Ishikawa H, Duker JS (2005) Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 112:1922.e1–1922.e15CrossRef Ko TH, Fujimoto JG, Schuman JS, Paunescu LA, Kowalevicz AM, Hartl I, Drexler W, Wollstein G, Ishikawa H, Duker JS (2005) Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 112:1922.e1–1922.e15CrossRef
9.
Zurück zum Zitat Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM Jr, Yannuzzi LA (2008) Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 145:509–517PubMedCrossRef Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM Jr, Yannuzzi LA (2008) Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol 145:509–517PubMedCrossRef
10.
Zurück zum Zitat Sayegh RG, Georgopoulos M, Geitzenauer W, Simader C, Kiss C, Schmidt-Erfurth U (2010) High-resolution optical coherence tomography after surgery for vitreomacular traction, a 2-year follow-up. Ophthalmology 117:2010–2017PubMedCrossRef Sayegh RG, Georgopoulos M, Geitzenauer W, Simader C, Kiss C, Schmidt-Erfurth U (2010) High-resolution optical coherence tomography after surgery for vitreomacular traction, a 2-year follow-up. Ophthalmology 117:2010–2017PubMedCrossRef
12.
Zurück zum Zitat Vinores SA, Amin A, Derevjanik NL, Green WR, Campochiaro PA (1994) Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular edema. Histochem J 26:655–665PubMedCrossRef Vinores SA, Amin A, Derevjanik NL, Green WR, Campochiaro PA (1994) Immunohistochemical localization of blood-retinal barrier breakdown sites associated with post-surgical macular edema. Histochem J 26:655–665PubMedCrossRef
13.
Zurück zum Zitat Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA (1997) Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12:99–109PubMed Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA (1997) Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12:99–109PubMed
14.
Zurück zum Zitat Mohamed Q, McIntosh RL, Saw SM, Wong TY (2007) Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 114:507–519PubMedCrossRef Mohamed Q, McIntosh RL, Saw SM, Wong TY (2007) Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 114:507–519PubMedCrossRef
15.
Zurück zum Zitat The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282 The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282
16.
Zurück zum Zitat De Geronimo F, Glacet-Bernard A, Coscas G, Soubrane G (2001) A quantitative in vivo study of retinal thickness before and after laser treatment for macular edema due to retinal vein occlusion. Eur J Ophthalmol 11:145–149PubMed De Geronimo F, Glacet-Bernard A, Coscas G, Soubrane G (2001) A quantitative in vivo study of retinal thickness before and after laser treatment for macular edema due to retinal vein occlusion. Eur J Ophthalmol 11:145–149PubMed
17.
Zurück zum Zitat Stahl A, Struebin I, Hansen LL, Agostini HT, Feltgen N (2010) Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatment. Eur J Ophthalmol 20:180–185PubMed Stahl A, Struebin I, Hansen LL, Agostini HT, Feltgen N (2010) Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatment. Eur J Ophthalmol 20:180–185PubMed
18.
Zurück zum Zitat Hoeh AE, Ach T, Schaal KB, Scheuerle AF, Dithmar S (2009) Long-term follow-up of OCT-guided bevacizumab treatment of macular oedema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247:1635–1641PubMedCrossRef Hoeh AE, Ach T, Schaal KB, Scheuerle AF, Dithmar S (2009) Long-term follow-up of OCT-guided bevacizumab treatment of macular oedema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 247:1635–1641PubMedCrossRef
19.
Zurück zum Zitat Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, Polak K, Schmidt-Erfurth U (2009) Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 93:452–456PubMedCrossRef Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, Polak K, Schmidt-Erfurth U (2009) Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 93:452–456PubMedCrossRef
20.
Zurück zum Zitat Rouvas A, Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I (2010) Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Retina 30:893–902PubMedCrossRef Rouvas A, Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I (2010) Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Retina 30:893–902PubMedCrossRef
21.
Zurück zum Zitat Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, Ozurdex Geneva Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134–1146PubMedCrossRef Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, Ozurdex Geneva Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134–1146PubMedCrossRef
22.
Zurück zum Zitat Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, Klein R (2009) Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol 147:298–306PubMedCrossRef Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, Klein R (2009) Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol 147:298–306PubMedCrossRef
23.
Zurück zum Zitat Noma H, Funatsu H, Mimura T, Shimada K (2010) Visual acuity and foveal thickness after vitrectomy for macular edema. Ophthalmologica 224:367–373PubMedCrossRef Noma H, Funatsu H, Mimura T, Shimada K (2010) Visual acuity and foveal thickness after vitrectomy for macular edema. Ophthalmologica 224:367–373PubMedCrossRef
24.
Zurück zum Zitat Park DH, Kim IT (2010) Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina 30:117–124PubMedCrossRef Park DH, Kim IT (2010) Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina 30:117–124PubMedCrossRef
25.
Zurück zum Zitat Raszewska-Steglinska M, Gozdek P, Cisiecki S, Michalewska Z, Michalewski J, Nawrocki J (2009) Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 19:1055–1062PubMed Raszewska-Steglinska M, Gozdek P, Cisiecki S, Michalewska Z, Michalewski J, Nawrocki J (2009) Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 19:1055–1062PubMed
26.
Zurück zum Zitat Shah GK, Sharma S, Fineman MS, Federman J, Brown MM, Brown GC (2000) Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 129:104–106PubMedCrossRef Shah GK, Sharma S, Fineman MS, Federman J, Brown MM, Brown GC (2000) Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 129:104–106PubMedCrossRef
27.
Zurück zum Zitat Tsujikawa A, Fujihara M, Iwawaki T, Yamamoto K, Kurimoto Y (2005) Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina 25:861–867PubMedCrossRef Tsujikawa A, Fujihara M, Iwawaki T, Yamamoto K, Kurimoto Y (2005) Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina 25:861–867PubMedCrossRef
28.
Zurück zum Zitat Sakuma T, Mizota A, Inoue J, Tanaka M (2010) Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 150(6):876–882CrossRef Sakuma T, Mizota A, Inoue J, Tanaka M (2010) Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 150(6):876–882CrossRef
29.
Zurück zum Zitat Lam HD, Blumenkranz MS (2002) Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection and photocoagulation. Am J Ophthalmol 134:609–611PubMedCrossRef Lam HD, Blumenkranz MS (2002) Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection and photocoagulation. Am J Ophthalmol 134:609–611PubMedCrossRef
30.
Zurück zum Zitat Rumelt S, Karatas M, Pikkel J, Majlin M, Ophir A (2003) Optic disc traction syndrome associated with central retinal vein occlusion. Arch Ophthalmol 121:1093–1097PubMedCrossRef Rumelt S, Karatas M, Pikkel J, Majlin M, Ophir A (2003) Optic disc traction syndrome associated with central retinal vein occlusion. Arch Ophthalmol 121:1093–1097PubMedCrossRef
31.
Zurück zum Zitat Fatum S, Trevino A, Ophir A (2009) Non-diabetic diffuse macular edema associated with extrafoveal vitreous traction. Isr Med Assoc J 11:286–290PubMed Fatum S, Trevino A, Ophir A (2009) Non-diabetic diffuse macular edema associated with extrafoveal vitreous traction. Isr Med Assoc J 11:286–290PubMed
32.
Zurück zum Zitat Ophir A, Trevino A, Martinez MR (2010) Extrafoveal vitreous traction associated with branch retinal vein occlusion. Eur J Ophthalmol 20(4):733–739PubMed Ophir A, Trevino A, Martinez MR (2010) Extrafoveal vitreous traction associated with branch retinal vein occlusion. Eur J Ophthalmol 20(4):733–739PubMed
33.
Zurück zum Zitat Johnson TM, Vaughn CW, Glaser BM (2006) Branch retinal vein occlusion associated with vitreoretinal traction. Can J Ophthalmol 41:600–602PubMed Johnson TM, Vaughn CW, Glaser BM (2006) Branch retinal vein occlusion associated with vitreoretinal traction. Can J Ophthalmol 41:600–602PubMed
34.
Zurück zum Zitat Ophir A, Trevino A, Fatum S (2010) Extrafoveal vitreous traction associated with diabetic diffuse macular oedema. Eye 24:347–353PubMedCrossRef Ophir A, Trevino A, Fatum S (2010) Extrafoveal vitreous traction associated with diabetic diffuse macular oedema. Eye 24:347–353PubMedCrossRef
35.
Zurück zum Zitat Ophir A, Martinez MR, Mosqueda P, Trevino A (2010) Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography. Eye 24:1545–1553PubMedCrossRef Ophir A, Martinez MR, Mosqueda P, Trevino A (2010) Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography. Eye 24:1545–1553PubMedCrossRef
36.
Zurück zum Zitat Hangai M, Ojima Y, Gotoh N, Inoue R, Yasuno Y, Makita S, Yamanari M, Yatagai T, Kita M, Yoshimura N (2007) Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 114:763–773PubMedCrossRef Hangai M, Ojima Y, Gotoh N, Inoue R, Yasuno Y, Makita S, Yamanari M, Yatagai T, Kita M, Yoshimura N (2007) Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology 114:763–773PubMedCrossRef
37.
Zurück zum Zitat Catier A, Tadayoni R, Paques M, Erginay A, Haouchine B, Gaudric A, Massin P (2005) Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol 140:200–206PubMedCrossRef Catier A, Tadayoni R, Paques M, Erginay A, Haouchine B, Gaudric A, Massin P (2005) Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol 140:200–206PubMedCrossRef
38.
Zurück zum Zitat Yamamoto S, Yamamoto T, Hayashi M, Takeuchi S (2001) Morphological and functional analyses of diabetic macular oedema by optical coherence tomography and multifocal electroretinograms. Graefes Arch Clin Exp Ophthalmol 239:96–101PubMedCrossRef Yamamoto S, Yamamoto T, Hayashi M, Takeuchi S (2001) Morphological and functional analyses of diabetic macular oedema by optical coherence tomography and multifocal electroretinograms. Graefes Arch Clin Exp Ophthalmol 239:96–101PubMedCrossRef
39.
Zurück zum Zitat Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A (2001) Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119:1135–1142PubMed Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A (2001) Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119:1135–1142PubMed
40.
Zurück zum Zitat Leizaola-Fernandez C, Suarez-Tata L, Quiroz-Mercado H, Colina-Luquez J, Fromow-Guerra J, Jiménez-Sierra JM, Guerrero-Naranjo JL, Morales-Cantón V (2005) Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol 5:10PubMedCrossRef Leizaola-Fernandez C, Suarez-Tata L, Quiroz-Mercado H, Colina-Luquez J, Fromow-Guerra J, Jiménez-Sierra JM, Guerrero-Naranjo JL, Morales-Cantón V (2005) Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol 5:10PubMedCrossRef
41.
Zurück zum Zitat Ma J, Yao K, Zhang Z, Tang X (2008) 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion. Retina 28:947–956PubMedCrossRef Ma J, Yao K, Zhang Z, Tang X (2008) 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion. Retina 28:947–956PubMedCrossRef
42.
Zurück zum Zitat Muqit MMK, Saidkasimova S, Keating D, Murdoch JR (2010) Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion. Acta Ophthalmol 88:e57–e65PubMedCrossRef Muqit MMK, Saidkasimova S, Keating D, Murdoch JR (2010) Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion. Acta Ophthalmol 88:e57–e65PubMedCrossRef
43.
Zurück zum Zitat Johnson MW (2010) Posterior vitreous detachment; evolution and complications of its early stages. Am J Ophthalmol 149:371–382PubMedCrossRef Johnson MW (2010) Posterior vitreous detachment; evolution and complications of its early stages. Am J Ophthalmol 149:371–382PubMedCrossRef
44.
Zurück zum Zitat Kishi S, Demaria C, Shimizu K (1986) Vitreous cortex remnants at the fovea after spontaneous vitreous detachment. Int Ophthalmol 9:253–260PubMedCrossRef Kishi S, Demaria C, Shimizu K (1986) Vitreous cortex remnants at the fovea after spontaneous vitreous detachment. Int Ophthalmol 9:253–260PubMedCrossRef
45.
Zurück zum Zitat Gandorfer A, Rohleder M, Grosselfinger S et al (2005) Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 139:638–652PubMedCrossRef Gandorfer A, Rohleder M, Grosselfinger S et al (2005) Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 139:638–652PubMedCrossRef
46.
Zurück zum Zitat Wilkinson CP, Rice TA, Michels R (1990) Retinal Detachment, 2nd edn. Mosby, St. Louis, pp 30–34 Wilkinson CP, Rice TA, Michels R (1990) Retinal Detachment, 2nd edn. Mosby, St. Louis, pp 30–34
47.
Zurück zum Zitat Gass JDM (1997) Stereoscopic atlas of macular diseases: diagnosis and treatment, 4th edn. Mosby, St. Louis, pp 904–951 Gass JDM (1997) Stereoscopic atlas of macular diseases: diagnosis and treatment, 4th edn. Mosby, St. Louis, pp 904–951
48.
Zurück zum Zitat Sebag J, Buckingham B, Charles MA, Reiser K (1992) Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 110:1472–1476PubMed Sebag J, Buckingham B, Charles MA, Reiser K (1992) Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 110:1472–1476PubMed
49.
Zurück zum Zitat Sebag J, Anomalous posterior vitreous detachment (2004) A unifying concept in vitreoretinal disease. Graefes Arch Clin Exp Ophthalmol 242:690–698PubMedCrossRef Sebag J, Anomalous posterior vitreous detachment (2004) A unifying concept in vitreoretinal disease. Graefes Arch Clin Exp Ophthalmol 242:690–698PubMedCrossRef
Metadaten
Titel
Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography
verfasst von
Michael R. Martinez
Avinoam Ophir
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 6/2011
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-011-1666-0

Weitere Artikel der Ausgabe 6/2011

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2011 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.